Zyter|TruCare Recogn
Zyter|TruCare Recognized as a Major Contender in Everest Group's 2024 PEAK Matrix® for Patient and Member Engagement Platforms
17 déc. 2024 09h00 HE | Zyter|TruCare
Rockville, Maryland, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Zyter|TruCare, a leading, clinically driven healthcare services and technology provider, proudly announces its recognition as a Major Contender...
Moxie Full logo 1x.png
Moxie Launches Compliance Defender to Simplify Regulatory Compliance for Medical Aesthetic Practices
16 déc. 2024 13h33 HE | Moxie Partners Inc.
Moxie launches Compliance Defender, a first-of-its-kind tool to help medspa owners simplify compliance, protect licenses, and prevent costly violations.
logoMelopnf.png
Melospeech Inc. revolutionizes speech therapy with launch of SLPeaceBot™ and CMSP:B-5
15 déc. 2024 02h51 HE | Melospeech Inc
Melospeech Inc. launches award-winning tools, SLPeaceBot™ & CMSP:B-5, empowering providers to streamline care and improve outcomes.
PHA logo.png
Premier Health Reports 2024 Fourth Quarter Results
10 déc. 2024 16h59 HE | Premier Health of America Inc.
PHA announces its Q4 and FY2024 results. It is reorganizing its Quebec operations to be more competitive in that market.
image8.png
M3 Group Joins MEDIROM Mother Labs’ Series A Financing Round at JPY9 Billion (as of December 1, 2024, approximately USD $59,000,000) Pre-Money Valuation
06 déc. 2024 16h30 HE | MEDIROM Healthcare Technologies Inc.
TOKYO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that M3, Inc. (TOKYO PRIME: 2413), or an affiliate within the M3 group, is...
Augmedix_logo (1).png
Augmedix Achieves Oracle Validation with Industry Healthcare Expertise for Delivering Proven, Repeatable Integration
04 déc. 2024 08h00 HE | Commure
SAN FRANCISCO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Augmedix, a Commure company and a member of Oracle PartnerNetwork (OPN), today announced that its has achieved Oracle Validated Integration with...
SoftServe Unveils Ne
SoftServe Unveils New Gen AI Solution ‘Drug Discovery,’ Built with NVIDIA Blueprints at AWS re:Invent 2024
03 déc. 2024 13h31 HE | SoftServe
AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug...
Smart Immune et CELL
Smart Immune et CELLforCURE by SEQENS s'associent pour industrialiser la production des lots cliniques de SMART101
03 déc. 2024 00h00 HE | Smart Immune
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
Smart Immune and CEL
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
03 déc. 2024 00h00 HE | Smart Immune
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
greylogo.png
VitalHub Announces Increase to Credit Facilities
02 déc. 2024 07h00 HE | VitalHub Corp.
TORONTO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has amended and expanded its existing credit facilities...